SlideShare a Scribd company logo
1
COMPUTER-AIDED FORMULATION
DEVELOPMENT & CONCEPT OF OPTIMIZATION
SUBMITTED BY
SHUBHAM KOTNALA
Department of Pharmaceutical
Sciences
BBAU Lucknow
CONTENTS
2
 Introduction.
 Advantages.
 Concept and terms.
 Optimization Parameters.
 Design Of Experiments.
 Conclusion.
 References.
3
 Formulation and development is a process of selection of
component and processing.
 Now days computer tools used in the formulation and
development of pharmaceutical product.
 Various technique, such as design of experiment are implemented
for optimization of formulation and processing parameter.
 Many times finding the correct answer is not simple and straight
forward in such cases use of computer tools (optimization
procedure) for best compromise is the smarter way to solve
problem.
INTRODUCTION
4
 The term Optimize is defined as to make perfect , effective, or
functional as possible.
 It is the process of finding the best way of using the existing
resources.
 While taking in to the account of all the factors that influences
decisions in any experiment.
 Traditionally, optimization in pharmaceuticals refers to
changing one variable at a time, so to obtain solution of a
problematic formulation.
ADVANTAGES
5
BASIC CONCEPT OF OPTIMIZATION &
TERMINOLOGY
6
 Various terminology and concept associated with optimization :-
 1.Variables.
 2.Effect, Interaction & Confounding.
 3.Code transformation.
 4. Factor space.
 5.Experimental design.
 6.Response surface.
VARIABLES
7
 Design and development of drug formulation or pharmaceutical
process usually involve several variables.
VARIBLES
QUANTITATIVE
(CAN BE ASSIGNED A
NO.)
Eg-AMOUNT OF
DISINTEGRANT,
QUALITATIVE
(NOT ASSIGNED A NO.
Eg- TYPE OF
EMULGENT,POLYMER
GRADE
INPUT VARIABLES
(INDEPENDENT VARIABLES)
Eg- MIXING TIME,
COMPRESSION FORCE
DEPENDENT
VARIABLES
(RESPONSE
VARIABLES)
8
 INDEPENDENT VARIABLES (INPUT VARIABLES)
 The independent variables, which influence the formulation
characteristics or output of the process, are labeled as
FACTORS.
 Values assigned to the factors are termed as LEVELS, e.g.,
30°and 50°are the levels for the factor, temperature.
 The restrictions placed on the factor levels are known as
CONSTRAINTS.
9
 DEPENDENT VARIABLES (RESPONSE VARIABLES)
 The characteristics of the finished drug product or the in-process
material are known as dependent.
 Variables, e.g., drug release profile, friability, size of tablet granules,
disintegration time, etc.
 These variables are the measured properties of the system to
estimate the outcome of the experiment.
 These variables are the direct function(s) of any change(s) in the
independent variables.
10
 Accordingly, a drug formulation (product) with respect to
optimization techniques can be considered as a system, whose
output (Y) is influenced by a set of controllable (X) and
uncontrollable (U) input variables via a transfer function (T).
 The nomenclature of T depends upon the predictability of the
output as an effect of change of the input variables.
T
System with controllable input variables (X),
uncontrollable input variables (U), transfer function (T) &
output variables (Y).
X
U
Y
11
 If the output is totally unpredictable from the previous studies,
T is termed as black box.
 The term, white box is used for a system with absolutely true
predictability.
 While the term, gray box is used for moderate.
EFFECT INTERACTION
&CONFOUNDING.
12
 The magnitude of the change in response caused by varying the
factor level(s) is termed as an EFFECT.
 The main effect is the effect of a factor averaged over all the levels
of other factors.
 An INTERACTION is said to occur, when there is "lack of
additivity of factor effects".
 An interaction may be said to take place when the effect of two or
more factors is dependent on each other, e.g., effect of factor A
depends on the level given to the factor B.
 The term orthogonality is used, if the estimated effects are due to
the main factor of interest and are independent of interactions
(Box et al., 1960; Bolton, 1990). Conversely, lack of orthogonality
(or independence) is termed as CONFOUNDING or .
 The measure of the degree of confounding is known as resolution.
CODE TRANSFORMATION
13
 The process of denoting a natural variable into a dimensionless
coded variable Xi such that the central value of experimental
domain is zero is known as coding or normalization.
 Various salient features of the transformation include:
 Depiction of effects and interaction using signs (+) or (-).
 Allocation of equal significance to each axis.
 Easier calculation of the coefficients.
 Easier calculation of the coefficient variances.
 Easier depiction of the response surfaces.
 Orthogonality of the effects.
14
 Generally, the various levels of a factor are designated as -1, 0
and +1, representing the lowest, intermediate (central) and the
highest factor levels investigated, respectively.
 For instance, if starch, a disintegrating agent, is studied as a factor
in the range of 5 to 10% (w/w), then codes -1 and +1 signify 5%
and 10% concentrations, respectively. The code 0 would represent
the central point at the mean of the two extremes, i.e., 7.5% w/w.
FACTOR SPACE
15
 The dimensional space defined by the coded variables is known
as factor space.
 The part of the factor space that is investigated experimentally
for optimization is the experimental domain , Also known as the
region of interest, it is enclosed by the upper and lower levels of
the variables.
 The factor space covers the entire figure area and extends even
beyond it, whereas the design space of the experimental domain
is the square enclosed by X1 = ± 1, X2 = ± 1.
 In Fig. represent the factor space for two factors on a bi-
dimensional (2-D) plane during a typical tablet compression
process.
16
Experimental Design
17
 Conduct of an experiment and subsequent interpretation of its
experimental outcome are the twin essential features of the
general scientific methodology.
 This can be accomplished only if the experiments are carried out
in a systematic way and the inferences are drawn accordingly.
 Runs or trials are the experiments conducted as per the selected
experimental design.
 Primarily, the experimental (or statistical) designs are based on
the principles of randomization (the manner of allocations of
treatments to the experimental units), replication (the number of
units employed for each treatment) and error control or local
control (grouping of specific type of experiments to increase the
precision).
RESPONSE SURFACE
18
 Conduct of DoE trials, as per the chosen statistical design, yields
a series of data on response variables explored. Such data can be
suitably modeled to generate mathematical relationship between
the independent variables and the dependent variable. Graphical
depiction of the mathematical relationship is known as Response
surface.
 A response surface plot is a 3-D graphical representation of a
response plotted between two independent variables and one
response variable. The use of 3-D response surface plots allows
understanding of the behavior of the system by demonstrating the
contribution of the independent variables.
DESIGN OF EXPERIMENT
19
 Design of experiment :- Is a structure organized method used to
determine the factor affecting to process and output of that process.
 Parsimony Principle:-
some of factor are important ,while other factor are not important.
 Few variables are effective or other are not effective.
 Experimental design is an integral part of optimization technique.
 Those technique used in the formulation optimization.
VARIOUS EXPERIMENTAL DESIGN
20
9
DOE FOR FORMULATION & DEVELOPMENT
21
 All pharmaceutical products are formulated to specific dosage form
drugs to be effectively delivered to patient typical pharmaceutical
dosage form include tablets, capsules, solution suspension, etc.
 Different dosage form required different technology usually
present different technological challenge for formulation &
development .
 Due to complex challenges, formulations scientist used effective
methodology like as design of experiment and statistical analysis
for formulation and development .
 Formulation scientist used this method for process optimization and
process validation .
COMPUTER SOFTWARE
22
Software Silent feature
Design Expert Powerful & compressive package used for optimizing
pharmaceutical formulation and process
Minitab Powerful DOE software for automated data analysis
MS-
Excel compatibility. Include almost all design of
RSM.
DOE PRO XL MS-Excel compatible DOE software for automated data
analysis
CARD Powerful DOE software for data analysis include
graphics
and help feature
CONCLUSION
23
 Design of experiment & statistical analysis have been
used in the formulation development.
 Using design of experiment formulation scientist evaluate the all
formulation factors in systematically and timely manner to
optimize the formulation and manufacturing process.
 When the pharmaceutical process and product are optimize by
systematic approach then process validation & scale up can be
efficient because of the robustness of the formulation and
manufacturing process.
REFERENCES
24
 Singh B, Gupta RK, Ahuja N. Computer-assisted optimization of
pharmaceutical formulations and processes. Pharmaceutical
Product Development (Ed. NK Jain), CBS Publishers, New Delhi.
2006:273-318.
 Cooper L. and Steinberg D., Introduction to methods of
optimization, W.B.Saunders,Philadelphia, 1970, 1st Edition, 301-
305.
25
Thank you
Any query??

More Related Content

PPTX
Computational modeling in drug disposition
PPTX
Targeted drug delivery system
PPTX
Computer aided formulation development
PDF
Computer simulation
PPTX
Computational modeling of drug disposition
PPTX
Computer aided biopharmaceutical characterization
PPTX
Sensitive analysis - Unit I (Computer aided drug development.pptx
PPTX
GI simulation final.pptx
Computational modeling in drug disposition
Targeted drug delivery system
Computer aided formulation development
Computer simulation
Computational modeling of drug disposition
Computer aided biopharmaceutical characterization
Sensitive analysis - Unit I (Computer aided drug development.pptx
GI simulation final.pptx

What's hot (20)

PPTX
Ethics of computing in pharmaceutical research
PPTX
Computers in Pharmaceutical formulation
PPTX
Formulation building blocks chap 3
PPTX
Tumour targeting and Brain specific drug delivery
PPTX
CONFIDENCE REGIONS AND CONCEPT OF NON LINEARITY
PPTX
Computer aided formulation development
PPTX
POPULATION MODELLING.pptx
PPTX
Formulation Building blocks: Building blocks for different product formulatio...
PPTX
Optimal design & Population mod pyn.pptx
PPTX
Computer simulation in pkpd
PPTX
Drug Distribution ,Drug Excretion, Active Transport; P–gp, BCRP, Nucleoside T...
PPTX
Antimicrobial preservatives
PDF
Statistical modeling in pharmaceutical research and development.
PPTX
Computational modeling of drug disposition
PPTX
REGULATORY AND INDUSTRY VIEWS ON QbD, SCIENTIFICALLY BASED QbD- EXAMPLES OF A...
PPTX
GASTROINTESTINAL ABSORPTION SIMULATION CADD.pptx
PPTX
computer in pharmaceutical formulation of microemlastion
PPTX
History of computers in pharmaceutical research and development
PDF
Proteins and peptide drug delivery system
PPTX
COMPUTER SIMULATIONS IN PHARMACOKINETICS & PHARMACODYNAMICS
Ethics of computing in pharmaceutical research
Computers in Pharmaceutical formulation
Formulation building blocks chap 3
Tumour targeting and Brain specific drug delivery
CONFIDENCE REGIONS AND CONCEPT OF NON LINEARITY
Computer aided formulation development
POPULATION MODELLING.pptx
Formulation Building blocks: Building blocks for different product formulatio...
Optimal design & Population mod pyn.pptx
Computer simulation in pkpd
Drug Distribution ,Drug Excretion, Active Transport; P–gp, BCRP, Nucleoside T...
Antimicrobial preservatives
Statistical modeling in pharmaceutical research and development.
Computational modeling of drug disposition
REGULATORY AND INDUSTRY VIEWS ON QbD, SCIENTIFICALLY BASED QbD- EXAMPLES OF A...
GASTROINTESTINAL ABSORPTION SIMULATION CADD.pptx
computer in pharmaceutical formulation of microemlastion
History of computers in pharmaceutical research and development
Proteins and peptide drug delivery system
COMPUTER SIMULATIONS IN PHARMACOKINETICS & PHARMACODYNAMICS
Ad

Similar to concept of optimization (20)

PPT
Optimizationinpharmaceuticsprocessing SIDDANNA M BALAPGOL
PPTX
Design of Experiments (DOE)
PDF
optimization.pdf
PPT
Optz.ppt
PDF
Design of Experiments and Optimization Techniques
PPTX
Optimization techniques in Pharmaceutical formulation and processing
PPTX
Optimization techniques
PDF
YMER210765.pdffffffff fddddddddddddddddd
PDF
unit- 5 Biostatistics and Research Methodology.pdf
PPTX
optimization in pharmaceutical formulations
PPT
Doe01 intro
PPTX
Concept of optimization, optimization parameters and factorial design
PPT
Optimization
PPTX
Experimental Design
PDF
RM_05_DOE.pdf
PPT
design of experiments
PPTX
UNIT 5.pptx
PPTX
Design of experiment
PPTX
UNIT 5.pptx
PPTX
study metarial-DOE-13-12 (1).pptx
Optimizationinpharmaceuticsprocessing SIDDANNA M BALAPGOL
Design of Experiments (DOE)
optimization.pdf
Optz.ppt
Design of Experiments and Optimization Techniques
Optimization techniques in Pharmaceutical formulation and processing
Optimization techniques
YMER210765.pdffffffff fddddddddddddddddd
unit- 5 Biostatistics and Research Methodology.pdf
optimization in pharmaceutical formulations
Doe01 intro
Concept of optimization, optimization parameters and factorial design
Optimization
Experimental Design
RM_05_DOE.pdf
design of experiments
UNIT 5.pptx
Design of experiment
UNIT 5.pptx
study metarial-DOE-13-12 (1).pptx
Ad

Recently uploaded (20)

PDF
Human Health And Disease hggyutgghg .pdf
PPTX
anal canal anatomy with illustrations...
PDF
شيت_عطا_0000000000000000000000000000.pdf
PPTX
LUNG ABSCESS - respiratory medicine - ppt
PPTX
ACID BASE management, base deficit correction
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PPTX
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PPTX
neonatal infection(7392992y282939y5.pptx
DOC
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
PDF
focused on the development and application of glycoHILIC, pepHILIC, and comm...
PPTX
Transforming Regulatory Affairs with ChatGPT-5.pptx
PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
PPTX
Cardiovascular - antihypertensive medical backgrounds
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
PPTX
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
Human Health And Disease hggyutgghg .pdf
anal canal anatomy with illustrations...
شيت_عطا_0000000000000000000000000000.pdf
LUNG ABSCESS - respiratory medicine - ppt
ACID BASE management, base deficit correction
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
MENTAL HEALTH - NOTES.ppt for nursing students
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
neonatal infection(7392992y282939y5.pptx
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
focused on the development and application of glycoHILIC, pepHILIC, and comm...
Transforming Regulatory Affairs with ChatGPT-5.pptx
OPIOID ANALGESICS AND THEIR IMPLICATIONS
Cardiovascular - antihypertensive medical backgrounds
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx

concept of optimization

  • 1. 1 COMPUTER-AIDED FORMULATION DEVELOPMENT & CONCEPT OF OPTIMIZATION SUBMITTED BY SHUBHAM KOTNALA Department of Pharmaceutical Sciences BBAU Lucknow
  • 2. CONTENTS 2  Introduction.  Advantages.  Concept and terms.  Optimization Parameters.  Design Of Experiments.  Conclusion.  References.
  • 3. 3  Formulation and development is a process of selection of component and processing.  Now days computer tools used in the formulation and development of pharmaceutical product.  Various technique, such as design of experiment are implemented for optimization of formulation and processing parameter.  Many times finding the correct answer is not simple and straight forward in such cases use of computer tools (optimization procedure) for best compromise is the smarter way to solve problem. INTRODUCTION
  • 4. 4  The term Optimize is defined as to make perfect , effective, or functional as possible.  It is the process of finding the best way of using the existing resources.  While taking in to the account of all the factors that influences decisions in any experiment.  Traditionally, optimization in pharmaceuticals refers to changing one variable at a time, so to obtain solution of a problematic formulation.
  • 6. BASIC CONCEPT OF OPTIMIZATION & TERMINOLOGY 6  Various terminology and concept associated with optimization :-  1.Variables.  2.Effect, Interaction & Confounding.  3.Code transformation.  4. Factor space.  5.Experimental design.  6.Response surface.
  • 7. VARIABLES 7  Design and development of drug formulation or pharmaceutical process usually involve several variables. VARIBLES QUANTITATIVE (CAN BE ASSIGNED A NO.) Eg-AMOUNT OF DISINTEGRANT, QUALITATIVE (NOT ASSIGNED A NO. Eg- TYPE OF EMULGENT,POLYMER GRADE INPUT VARIABLES (INDEPENDENT VARIABLES) Eg- MIXING TIME, COMPRESSION FORCE DEPENDENT VARIABLES (RESPONSE VARIABLES)
  • 8. 8  INDEPENDENT VARIABLES (INPUT VARIABLES)  The independent variables, which influence the formulation characteristics or output of the process, are labeled as FACTORS.  Values assigned to the factors are termed as LEVELS, e.g., 30°and 50°are the levels for the factor, temperature.  The restrictions placed on the factor levels are known as CONSTRAINTS.
  • 9. 9  DEPENDENT VARIABLES (RESPONSE VARIABLES)  The characteristics of the finished drug product or the in-process material are known as dependent.  Variables, e.g., drug release profile, friability, size of tablet granules, disintegration time, etc.  These variables are the measured properties of the system to estimate the outcome of the experiment.  These variables are the direct function(s) of any change(s) in the independent variables.
  • 10. 10  Accordingly, a drug formulation (product) with respect to optimization techniques can be considered as a system, whose output (Y) is influenced by a set of controllable (X) and uncontrollable (U) input variables via a transfer function (T).  The nomenclature of T depends upon the predictability of the output as an effect of change of the input variables. T System with controllable input variables (X), uncontrollable input variables (U), transfer function (T) & output variables (Y). X U Y
  • 11. 11  If the output is totally unpredictable from the previous studies, T is termed as black box.  The term, white box is used for a system with absolutely true predictability.  While the term, gray box is used for moderate.
  • 12. EFFECT INTERACTION &CONFOUNDING. 12  The magnitude of the change in response caused by varying the factor level(s) is termed as an EFFECT.  The main effect is the effect of a factor averaged over all the levels of other factors.  An INTERACTION is said to occur, when there is "lack of additivity of factor effects".  An interaction may be said to take place when the effect of two or more factors is dependent on each other, e.g., effect of factor A depends on the level given to the factor B.  The term orthogonality is used, if the estimated effects are due to the main factor of interest and are independent of interactions (Box et al., 1960; Bolton, 1990). Conversely, lack of orthogonality (or independence) is termed as CONFOUNDING or .  The measure of the degree of confounding is known as resolution.
  • 13. CODE TRANSFORMATION 13  The process of denoting a natural variable into a dimensionless coded variable Xi such that the central value of experimental domain is zero is known as coding or normalization.  Various salient features of the transformation include:  Depiction of effects and interaction using signs (+) or (-).  Allocation of equal significance to each axis.  Easier calculation of the coefficients.  Easier calculation of the coefficient variances.  Easier depiction of the response surfaces.  Orthogonality of the effects.
  • 14. 14  Generally, the various levels of a factor are designated as -1, 0 and +1, representing the lowest, intermediate (central) and the highest factor levels investigated, respectively.  For instance, if starch, a disintegrating agent, is studied as a factor in the range of 5 to 10% (w/w), then codes -1 and +1 signify 5% and 10% concentrations, respectively. The code 0 would represent the central point at the mean of the two extremes, i.e., 7.5% w/w.
  • 15. FACTOR SPACE 15  The dimensional space defined by the coded variables is known as factor space.  The part of the factor space that is investigated experimentally for optimization is the experimental domain , Also known as the region of interest, it is enclosed by the upper and lower levels of the variables.  The factor space covers the entire figure area and extends even beyond it, whereas the design space of the experimental domain is the square enclosed by X1 = ± 1, X2 = ± 1.  In Fig. represent the factor space for two factors on a bi- dimensional (2-D) plane during a typical tablet compression process.
  • 16. 16
  • 17. Experimental Design 17  Conduct of an experiment and subsequent interpretation of its experimental outcome are the twin essential features of the general scientific methodology.  This can be accomplished only if the experiments are carried out in a systematic way and the inferences are drawn accordingly.  Runs or trials are the experiments conducted as per the selected experimental design.  Primarily, the experimental (or statistical) designs are based on the principles of randomization (the manner of allocations of treatments to the experimental units), replication (the number of units employed for each treatment) and error control or local control (grouping of specific type of experiments to increase the precision).
  • 18. RESPONSE SURFACE 18  Conduct of DoE trials, as per the chosen statistical design, yields a series of data on response variables explored. Such data can be suitably modeled to generate mathematical relationship between the independent variables and the dependent variable. Graphical depiction of the mathematical relationship is known as Response surface.  A response surface plot is a 3-D graphical representation of a response plotted between two independent variables and one response variable. The use of 3-D response surface plots allows understanding of the behavior of the system by demonstrating the contribution of the independent variables.
  • 19. DESIGN OF EXPERIMENT 19  Design of experiment :- Is a structure organized method used to determine the factor affecting to process and output of that process.  Parsimony Principle:- some of factor are important ,while other factor are not important.  Few variables are effective or other are not effective.  Experimental design is an integral part of optimization technique.  Those technique used in the formulation optimization.
  • 21. DOE FOR FORMULATION & DEVELOPMENT 21  All pharmaceutical products are formulated to specific dosage form drugs to be effectively delivered to patient typical pharmaceutical dosage form include tablets, capsules, solution suspension, etc.  Different dosage form required different technology usually present different technological challenge for formulation & development .  Due to complex challenges, formulations scientist used effective methodology like as design of experiment and statistical analysis for formulation and development .  Formulation scientist used this method for process optimization and process validation .
  • 22. COMPUTER SOFTWARE 22 Software Silent feature Design Expert Powerful & compressive package used for optimizing pharmaceutical formulation and process Minitab Powerful DOE software for automated data analysis MS- Excel compatibility. Include almost all design of RSM. DOE PRO XL MS-Excel compatible DOE software for automated data analysis CARD Powerful DOE software for data analysis include graphics and help feature
  • 23. CONCLUSION 23  Design of experiment & statistical analysis have been used in the formulation development.  Using design of experiment formulation scientist evaluate the all formulation factors in systematically and timely manner to optimize the formulation and manufacturing process.  When the pharmaceutical process and product are optimize by systematic approach then process validation & scale up can be efficient because of the robustness of the formulation and manufacturing process.
  • 24. REFERENCES 24  Singh B, Gupta RK, Ahuja N. Computer-assisted optimization of pharmaceutical formulations and processes. Pharmaceutical Product Development (Ed. NK Jain), CBS Publishers, New Delhi. 2006:273-318.  Cooper L. and Steinberg D., Introduction to methods of optimization, W.B.Saunders,Philadelphia, 1970, 1st Edition, 301- 305.